These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 17418455

  • 1. Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice.
    Song S, Wang F, He X, He Y, Li D, Sun S.
    Vaccine; 2007 Jun 15; 25(25):4853-60. PubMed ID: 17418455
    [Abstract] [Full Text] [Related]

  • 2. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A, Chatterjee SK, Foon KA, Celis E, Bhattacharya-Chatterjee M.
    Cancer Res; 2007 Mar 15; 67(6):2881-92. PubMed ID: 17363612
    [Abstract] [Full Text] [Related]

  • 3. An HLA-A2 polyepitope vaccine for melanoma immunotherapy.
    Mateo L, Gardner J, Chen Q, Schmidt C, Down M, Elliott SL, Pye SJ, Firat H, Lemonnier FA, Cebon J, Suhrbier A.
    J Immunol; 1999 Oct 01; 163(7):4058-63. PubMed ID: 10491010
    [Abstract] [Full Text] [Related]

  • 4. A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses.
    Conforti A, Peruzzi D, Giannetti P, Biondo A, Ciliberto G, La Monica N, Aurisicchio L.
    J Immunother; 2009 Sep 01; 32(7):744-54. PubMed ID: 19561534
    [Abstract] [Full Text] [Related]

  • 5. [Establishment of B16-HLA-MAGE-3 melanoma cell line coexpressing HLA-A 0201/K(b) and MAGE-3 and its role in tumor vaccine evaluation].
    Song SX, Yan CZ, Zheng L, You HY, Wang JX, Liu FY.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jul 01; 24(7):679-82. PubMed ID: 18616910
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients.
    Jaramillo A, Narayanan K, Campbell LG, Benshoff ND, Lybarger L, Hansen TH, Fleming TP, Dietz JR, Mohanakumar T.
    Breast Cancer Res Treat; 2004 Nov 01; 88(1):29-41. PubMed ID: 15538043
    [Abstract] [Full Text] [Related]

  • 8. Immunogenic HLA-B*0702-restricted epitopes derived from human telomerase reverse transcriptase that elicit antitumor cytotoxic T-cell responses.
    Adotévi O, Mollier K, Neuveut C, Cardinaud S, Boulanger E, Mignen B, Fridman WH, Zanetti M, Charneau P, Tartour E, Lemonnier F, Langlade-Demoyen P.
    Clin Cancer Res; 2006 May 15; 12(10):3158-67. PubMed ID: 16707616
    [Abstract] [Full Text] [Related]

  • 9. Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma.
    Komori H, Nakatsura T, Senju S, Yoshitake Y, Motomura Y, Ikuta Y, Fukuma D, Yokomine K, Harao M, Beppu T, Matsui M, Torigoe T, Sato N, Baba H, Nishimura Y.
    Clin Cancer Res; 2006 May 01; 12(9):2689-97. PubMed ID: 16675560
    [Abstract] [Full Text] [Related]

  • 10. Identification of interleukin-13 receptor alpha2 peptide analogues capable of inducing improved antiglioma CTL responses.
    Eguchi J, Hatano M, Nishimura F, Zhu X, Dusak JE, Sato H, Pollack IF, Storkus WJ, Okada H.
    Cancer Res; 2006 Jun 01; 66(11):5883-91. PubMed ID: 16740728
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1.
    Ishizaki H, Tsunoda T, Wada S, Yamauchi M, Shibuya M, Tahara H.
    Clin Cancer Res; 2006 Oct 01; 12(19):5841-9. PubMed ID: 17020992
    [Abstract] [Full Text] [Related]

  • 12. HLA-A2 and -A24-restricted glypican-3-derived peptide vaccine induces specific CTLs: preclinical study using mice.
    Motomura Y, Ikuta Y, Kuronuma T, Komori H, Ito M, Tsuchihara M, Tsunoda Y, Shirakawa H, Baba H, Nishimura Y, Kinoshita T, Nakatsura T.
    Int J Oncol; 2008 May 01; 32(5):985-90. PubMed ID: 18425324
    [Abstract] [Full Text] [Related]

  • 13. Enhanced multiepitope-based vaccines elicit CD8+ cytotoxic T cells against both immunodominant and cryptic epitopes.
    Tine JA, Firat H, Payne A, Russo G, Davis SW, Tartaglia J, Lemonnier FA, Demoyen PL, Moingeon P.
    Vaccine; 2005 Jan 11; 23(8):1085-91. PubMed ID: 15620483
    [Abstract] [Full Text] [Related]

  • 14. A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo.
    Tu SH, Huang HI, Lin SI, Liu HY, Sher YP, Chiang SK, Chong P, Roffler S, Tseng GC, Chen HW, Liu SJ.
    J Immunother; 2012 Apr 11; 35(3):235-44. PubMed ID: 22421941
    [Abstract] [Full Text] [Related]

  • 15. Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.
    Nanjundappa RH, Wang R, Xie Y, Umeshappa CS, Xiang J.
    Vaccine; 2012 May 21; 30(24):3519-25. PubMed ID: 22484292
    [Abstract] [Full Text] [Related]

  • 16. Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy.
    Machlenkin A, Paz A, Bar Haim E, Goldberger O, Finkel E, Tirosh B, Volovitz I, Vadai E, Lugassy G, Cytron S, Lemonnier F, Tzehoval E, Eisenbach L.
    Cancer Res; 2005 Jul 15; 65(14):6435-42. PubMed ID: 16024648
    [Abstract] [Full Text] [Related]

  • 17. Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct.
    Cardinaud S, Bouziat R, Rohrlich PS, Tourdot S, Weiss L, Langlade-Demoyen P, Burgevin A, Fiorentino S, van Endert P, Lemonnier FA.
    AIDS; 2009 Sep 24; 23(15):1945-54. PubMed ID: 19644347
    [Abstract] [Full Text] [Related]

  • 18. Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements.
    Huarte E, Sarobe P, Lu J, Casares N, Lasarte JJ, Dotor J, Ruiz M, Prieto J, Celis E, Borrás-Cuesta F.
    Clin Cancer Res; 2002 Jul 24; 8(7):2336-44. PubMed ID: 12114438
    [Abstract] [Full Text] [Related]

  • 19. Response of established human breast tumors to vaccination with mammaglobin-A cDNA.
    Narayanan K, Jaramillo A, Benshoff ND, Campbell LG, Fleming TP, Dietz JR, Mohanakumar T.
    J Natl Cancer Inst; 2004 Sep 15; 96(18):1388-96. PubMed ID: 15367572
    [Abstract] [Full Text] [Related]

  • 20. Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice.
    Hu N, D'Souza C, Cheung H, Lang H, Cheuk E, Chamberlain JW.
    Vaccine; 2005 Nov 01; 23(45):5231-44. PubMed ID: 16099553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.